Ikena Oncology, Inc.

Historical 13F Holders

Symbol
IKNA
CUSIP
45175G108
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 45175G108 since 12/18/2024, largest first.

Filer % of Class Filed
Orbimed Advisors LLC 13D/A
13.1% 4/29/2026
Event 4/14/2026
Biotechnology Value Fund L P 13G/A
8.3% 2/14/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
BML Investment Partners, L.P. 13D
Amended under CUSIP 45175G207 on 7/28/2025
8.5% 6/16/2025
Event 6/16/2025
Gilead Sciences, Inc. 13G/A 3.6% 2/13/2025
Event 12/31/2024
Deep Track Capital, LP 13G/A
0% 8/4/2025
Event 7/28/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q2 42 31.8 M $42.6M
2025 Q1 47 32.7 M $41.9M
2024 Q4 54 31.7 M $52.0M
2024 Q3 58 28.4 M $49.1M
2024 Q2 71 29.0 M $47.9M
2024 Q1 58 30.1 M $42.7M
2023 Q4 55 32.4 M $63.8M
2023 Q3 59 32.7 M $142M
2023 Q2 53 31.2 M $205M
2023 Q1 40 25.0 M $86.2M
2022 Q4 35 26.3 M $69.9M
2022 Q3 43 26.2 M $93.2M
2022 Q2 47 26.8 M $119M
2022 Q1 49 27.5 M $168M
2021 Q4 50 27.4 M $344M
2021 Q3 40 20.9 M $272M
2021 Q2 43 21.1 M $293M
2021 Q1 28 19.3 M $539M